Cellectar Biosciences Inc (CLRB)
3.085
+0.04
(+1.48%)
USD |
NASDAQ |
May 31, 16:00
3.085
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Price to Book Value: 12.17 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 12.17 |
| May 30, 2024 | 11.99 |
| May 29, 2024 | 11.64 |
| May 28, 2024 | 11.68 |
| May 24, 2024 | 12.27 |
| May 23, 2024 | 12.07 |
| May 22, 2024 | 12.62 |
| May 21, 2024 | 12.82 |
| May 20, 2024 | 12.47 |
| May 17, 2024 | 13.02 |
| May 16, 2024 | 13.14 |
| May 15, 2024 | 13.25 |
| May 14, 2024 | 12.54 |
| May 13, 2024 | 12.07 |
| May 10, 2024 | 12.11 |
| May 09, 2024 | 12.78 |
| May 08, 2024 | 12.62 |
| May 07, 2024 | 12.98 |
| May 06, 2024 | 13.14 |
| May 03, 2024 | 13.49 |
| May 02, 2024 | 13.18 |
| May 01, 2024 | 12.47 |
| April 30, 2024 | 12.19 |
| April 29, 2024 | 12.23 |
| April 26, 2024 | 11.95 |
| Date | Value |
|---|---|
| April 25, 2024 | 11.91 |
| April 24, 2024 | 12.07 |
| April 23, 2024 | 11.35 |
| April 22, 2024 | 11.64 |
| April 19, 2024 | 11.06 |
| April 18, 2024 | 11.09 |
| April 17, 2024 | 11.71 |
| April 16, 2024 | 12.08 |
| April 15, 2024 | 12.12 |
| April 12, 2024 | 12.81 |
| April 11, 2024 | 13.54 |
| April 10, 2024 | 12.74 |
| April 09, 2024 | 13.61 |
| April 08, 2024 | 13.90 |
| April 05, 2024 | 13.72 |
| April 04, 2024 | 13.58 |
| April 03, 2024 | 14.52 |
| April 02, 2024 | 14.56 |
| April 01, 2024 | 14.31 |
| March 28, 2024 | |
| March 27, 2024 | |
| March 26, 2024 | |
| March 25, 2024 | |
| March 22, 2024 | |
| March 21, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.828
Minimum
May 12 2022
14.56
Maximum
Apr 02 2024
2.404
Average
1.724
Median
Aug 20 2020
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 3.738 |
| Eli Lilly and Co | 60.85 |
| Actinium Pharmaceuticals Inc | 5.535 |
| Altimmune Inc | 3.079 |
| GlycoMimetics Inc | 0.6057 |
Price to Book Value Related Metrics
| Price | 3.085 |
| Earnings Yield | -99.84% |
| Market Cap | 110.59M |